Azenta, Inc. (AZTA) Revenue History
Azenta, Inc. (AZTA) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-09-30 | $560.32M |
| 2017-09-30 | $527.50M |
| 2018-09-30 | $631.56M |
| 2019-09-30 | $780.85M |
| 2020-09-30 | $388.54M |
| 2021-09-30 | $513.70M |
| 2022-09-30 | $555.50M |
| 2023-09-30 | $665.07M |
| 2024-09-30 | $573.45M |
| 2025-09-30 | $593.82M |
How AZTA compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | $673.00M |
| AXSM | Axsome Therapeutics Inc. | $638.50M |
| TGTX | TG Therapeutics Inc. | $616.29M |
| ATRC | AtriCure Inc. | $534.53M |
| VCYT | Veracyte Inc. | $517.14M |
These are five companies in the same sector as AZTA with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Azenta, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("AZTA", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | AZTA | $32.88 | -12.09% | 1.90M |
| 3 | ||||
| 4 | ||||
| 5 |